Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.
Scan.com Raises $220 Million to Build the Largest Medical Imaging Network in the US
Scan.com has closed $220 million in combined equity and debt financing after doubling revenue over the past year to surpass a $165 million annualized run rate. The new Series C equity round and debt facilities will expand Scan.com’s US footprint and help it become the preeminent diagnostic imaging infrastructure across the nation.
The $90 million equity round was led by Noteus Partners, with participation from Aviva, Concord Health Partners, YZR Capital, Oxford Capital, and others. $130 million of debt facilities supporting M&A and working capital were provided by VerisFi Capital and Atempo Growth.
A $100 Billion Market that is Still Largely Offline
Valued at over $100 billion, the US medical imaging market is one of the largest segments of American healthcare. It is also slow, expensive, fragmented, and still largely offline, with 85% of scans still booked via fax or phone. Patients often wait weeks for a scan, and a national shortage of radiologists and technologists adds further pressure on the system.
Scan.com’s data shows that the same MRI can cost a few hundred dollars at one center and several thousand at another a few miles away, where price is a poor guide to quality. At the same time…
Full release here, originally announced August 31st, 2026.
Thyme Care Closes $125+ Million Series E, Establishes Thyme Companies to Broaden Its Impact Across the Oncology Ecosystem
Thyme Care, the nationally recognized oncology company, today announced a new Series E financing round of over $125M. Morgan Health led the round, with participation from strategic healthcare investors Humana and CVS Health Ventures, as well as institutional investors AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health.
The financing brings together strategic investors from across the cancer care ecosystem, including the largest national payers, community oncology, health systems, and leaders in employer-sponsored health care, reflecting favorable investor outlook on Thyme Care’s care model and its potential to take on the broader challenges in cancer care. Today, Thyme Care services are available to more than 10.5 million people across all 50 states, and the company manages more than $7 billion in oncology spend. By aligning care around the patient, the model delivers 5 to 10 percent validated reductions in total cost of care, creating measurable value for patients, providers, and health plan partners. Supported by strong financial discipline, Thyme Care is profitable, generates meaningful positive free cash flow, and is positioned to accelerate its next phase of growth.
“People living with cancer have traditionally been left to coordinate care themselves and pay more along the way. Thyme Care is changing that experience and making it possible to improve cancer care while lowering costs,” said Dan Mendelson, Chief Executive Officer at Morgan Health…
Full release here, originally announced September 2nd, 2026.
No comments:
Post a Comment